Atopic Dermatitis Treatment Market By Product (Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others), By Route of Administration (Oral, Topical, Injectable), By End-Users (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), and By Region - Trends, Analysis and Forecast till 2034

Atopic dermatitis and eczema are becoming more common, which has significantly impacted the target market's growth. Eczema has developed and progressed due to a combination of factors including genetics, environmental exposure, and changing lifestyle choices. For example, the National Eczema Association estimates that 31.6 million Americans suffer from eczema, a very inflammatory skin condition that usually appears in the first year of life.

Furthermore, the Centers for Disease Control and Prevention (CDC) reports that in the United States in 2021, the percentage of adults with eczema diagnoses varied by age, sex, race, and Hispanic origin. Women had a higher percentage of eczema (8.9%) than men did (about 5.7%).